Role of elevated pressure in TRAIL-induced apoptosis in human lung carcinoma cells

被引:0
|
作者
Sangnam Oh
Daeho Kwon
Hyun Jeong Lee
Joonhee Kim
Eunil Lee
机构
[1] Cellular and Developmental Biology,Department of Preventive Medicine and Medical Research Center for Environmental Toxico
[2] Division of Biomedical Science,Genomics and Proteomics, College of Medicine
[3] Korea University,Avian Disease Laboratory, College of Veterinary Medicine
[4] Konkuk University,undefined
来源
Apoptosis | 2010年 / 15卷
关键词
Elevated pressure; TNF-related apoptosis-inducing ligand (TRAIL); Apoptosis; Cancer therapy;
D O I
暂无
中图分类号
学科分类号
摘要
TNF-related apoptosis-inducing ligand (TRAIL, Apo2L) is a promising anticancer agent with high specificity for cancer cells. Many strategies have been proposed to enhance the sensitivity of cancer cells to TRAIL-mediated apoptosis, including the use of combination treatment with conventional cancer therapies. However, few reports have evaluated the effects of TRAIL in combination with mechanical stress, which can also cause apoptosis of cancer cells. In the present study, we describe a custom-designed culture system that delivers two atmospheres of elevated pressure (EP) by using compressed air, and which enhances the sensitivity of cancer cells to TRAIL-mediated apoptosis. The combination of TRAIL and EP significantly increased apoptosis of human H460 lung cancer cells more than hyperbaric normoxia or normobaric mild hyperoxia. EP-potentiating TRAIL-mediated apoptosis of H460 cells was accompanied by up-regulated death receptor 5 (DR5), activation of caspases, decreased mitochondrial membrane potential, and reactive oxygen species production. We also observed EP-induced sensitization of TRAIL-mediated apoptosis in other cancer cell types. In contrast, human normal cells showed no DNA damage or cell death when exposed to the combined treatment. In a chicken chorioallantoic membrane model, EP enhanced TRAIL-mediated apoptosis of tumors that developed from transplanted H460 cells. Collectively, EP enhanced TRAIL-induced apoptosis of human lung carcinoma cells in vitro and in vivo. These findings suggest that EP is a mechanical and physiological stimulus that might have utility as a sensitizing tool for cancer therapy.
引用
收藏
页码:1517 / 1528
页数:11
相关论文
共 50 条
  • [41] Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis
    Koschny, Ronald
    Holland, Heidrun
    Sykora, Jaromir
    Erdal, Hande
    Krupp, Wolfgang
    Bauer, Manfred
    Bockmuehl, Ulrike
    Ahnert, Peter
    Meixensberger, Jurgen
    Stremmel, Wolfgang
    Walczak, Henning
    Ganten, Tom M.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 97 (02) : 171 - 185
  • [42] Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis
    Ronald Koschny
    Heidrun Holland
    Jaromir Sykora
    Hande Erdal
    Wolfgang Krupp
    Manfred Bauer
    Ulrike Bockmuehl
    Peter Ahnert
    Jürgen Meixensberger
    Wolfgang Stremmel
    Henning Walczak
    Tom M. Ganten
    Journal of Neuro-Oncology, 2010, 97 : 171 - 185
  • [43] Resistance and susceptibility of human uveal melanoma cells to TRAIL-Induced apoptosis
    Li, HC
    Niederkorn, JY
    Neelam, S
    Alizadeh, H
    ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (05) : 654 - 661
  • [44] Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells
    Dong, Bingfei
    Lv, Guoyue
    Wang, Quan
    Wang, Guangyi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 418 (02) : 433 - 438
  • [45] The Akt inhibitor triciribine sensitizes prostate carcinoma cells to TRAIL-induced apoptosis
    Dieterle, Alexandra
    Orth, Ronald
    Daubrawa, Merle
    Grotemeier, Antje
    Alers, Sebastian
    Ullrich, Susanne
    Lammers, Reiner
    Wesselborg, Sebastian
    Stork, Bjoern
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (04) : 932 - 941
  • [46] Inhibiting Survivin Expression Enhances Trail-Induced Apoptosis in Human Hepatocellular Carcinoma
    He, Song-Qing
    Gong, Ming-Guang
    Huang, Zhi-Yong
    Li, Chang-Hai
    Zhang, Wan-Guang
    Wu, Jian
    Chen, Xiao-Ping
    MOLECULAR THERAPY, 2006, 13 : S364 - S365
  • [47] Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis
    Kim, JY
    Kim, YH
    Chang, I
    Kim, S
    Pak, YK
    Oh, BH
    Yagita, H
    Jung, YK
    Oh, YJ
    Lee, MS
    ONCOGENE, 2002, 21 (20) : 3139 - 3148
  • [48] Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis
    Ja-Young Kim
    Yun-Hee Kim
    Inik Chang
    Sunshin Kim
    Youngmi Kim Pak
    Byung-Ha Oh
    Hideo Yagita
    Yong Keun Jung
    Young Joon Oh
    Myung-Shik Lee
    Oncogene, 2002, 21 : 3139 - 3148
  • [49] Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis
    Ou, Yen-Chuan
    Li, Jian-Ri
    Kuan, Yu-Hsiang
    Raung, Shue-Ling
    Wang, Chung-Chiang
    Hung, Yu-Yeh
    Pan, Pin-Ho
    Lu, Hsi-Chi
    Chen, Chun-Jung
    LIFE SCIENCES, 2014, 100 (02) : 110 - 117
  • [50] cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis
    Guicciardi, Maria Eugenia
    Bronk, Steven F.
    Werneburg, Nathan W.
    Gores, Gregory J.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2007, 292 (05): : G1337 - G1346